Technology News and Research

RSS

Avacta enters into manufacturing agreement with Abingdon Health for rapid SARS-CoV-2 antigen test

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into an agreement with Abingdon Health for the manufacture of Avacta’s saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing expansion of manufacturing capacity.

From Avacta Life Sciences Ltd. 3 Sep 2020

Remote delivery of mental health care across the U.S. has increased dramatically

The COVID-19 pandemic has spurred a remarkable number of psychologists across the United States to shift to delivering mental health care to patients remotely, according to a national study led by researchers at Virginia Commonwealth University.

3 Sep 2020

Magnetic resonance elastography can improve the detection of epilepsy

A new study uses magnetic resonance elastography to compare the stiffness of the hippocampus in patients who have epilepsy with healthy individuals. The technique can improve the detection and characterization of the disease.

2 Sep 2020

Telerehabilitation works for people recovering from stroke

While virtual medical and rehabilitation appointments seemed novel when COVID-19 first appeared, they now seem to be part of the new norm and might be paving the way to the future.

2 Sep 2020

Researchers create new and quicker method of diagnosing diseases

A new and quicker method of diagnosing diseases in patients has been created by researchers at the University of Leeds.

2 Sep 2020

Study identifies subtypes and developmental process of novel immune T cells

There are memory cells that remember previously encountered pathogens and help to react quickly and strongly when exposed to them again.

2 Sep 2020

FDA grants rare disease designations to investigational brain tumor drug

The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahoma Medical Research Foundation and being developed by Oblato, Inc.

2 Sep 2020

NIH provides scale-up and manufacturing support for new COVID-19 testing technologies

The National Institutes of Health today announced $129.3 million in scale-up and manufacturing support for a new set of COVID-19 testing technologies as part of its Rapid Acceleration of Diagnostics (RADx) initiative.

2 Sep 2020

Health officials worry nation is not ready for COVID-19 vaccine

Millions of Americans are counting on a COVID-19 vaccine to curb the global pandemic and return life to normal.

2 Sep 2020

Study reveals the unexpected benefits of telehealth services

Expanded telehealth services at UT Southwestern have proved effective at safely delivering patient care during the pandemic, leading to an increase in patients even in specialties such as plastic surgery, according to a new study.

2 Sep 2020

High-pressure preconcentration devices for detecting small amounts of virus in early infections

Diagnostic devices that are used at home or in doctors' offices are often not sensitive enough to detect small amounts of a virus that might be present in samples from asymptomatic patients, which can occur in early stage COVID-19.

1 Sep 2020

Addressing food insecurity in school children during COVID-19 pandemic

The coronavirus pandemic has brought a number of challenges to schools, which were forced to close in the spring to help slow the spread of infection.

1 Sep 2020

Yale trial tests new tool to address health disparities in treatment of alcohol use disorders

Yale researchers are completing a first-of-its-kind clinical trial to test the efficacy of an automated bilingual alcohol screening and intervention tool for use in emergency departments (EDs).

1 Sep 2020

Promising new candidate 'virus-like particle' vaccine for COVID-19

Researchers in the UK and Taiwan have demonstrated the potential of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

1 Sep 2020

Study offers hope for Norwegians suffering from chronic sleep disorders

Approximately 500 000 Norwegians suffer from chronic sleep disorders, also called insomnia. Researchers have long known that cognitive behavioural therapy for insomnia is the best documented treatment, but few people have access to such therapy.

1 Sep 2020

AXT to Bring Poietis Next-Gen Bioprinters to Australia

AXT are proud to announce that they have partnered with France-based Poietis to bring their next-generation bioprinting platforms to Australia.

From AXT Pty Ltd 1 Sep 2020

SAGE and Hindawi sign publishing partnership agreement

SAGE and Hindawi have recently entered into a publishing partnership agreement whereby the latter will publish and develop three SAGE gold open access journals for a period of at least three years.

1 Sep 2020

Innovative training protocol leads to real physical and cognitive benefits

Researchers at the Smart-Aging Research Center (IDAC) at Tohoku University have developed an innovative training protocol that, utilizing immersive virtual reality (IVR), leads to real physical and cognitive benefits.

1 Sep 2020

Rapid COVID-19 test could enable point-of-care diagnosis

As COVID-19 continues to spread, bottlenecks in supplies and laboratory personnel have led to long waiting times for results in some areas.

1 Sep 2020

Heart structure could explain why risk of heart disease differs between men and women

Differences in the shape and texture of men and women's hearts could potentially explain why their risk of heart disease differs, according to research funded by the British Heart Foundation (BHF).

1 Sep 2020